HIV Citations List: March 2025

Literature Citations

1. Structures of Complete HIV-1 TAR RNA Portray a Dynamic Platform Poised for Protein Binding and Structural Remodeling. Bou-Nader, C., K.A. Link, K.C. Suddala, J.R. Knutson, and J. Zhang. Nature Communications, 2025. 16(1): p. 2252. PMID[40050622]. PMCID[PMC11885821].
[PubMed]. HIV_03_2025.

2. Structure-Based Discovery of Novel Diarylpyrimidines as Potent and Selective Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-Biphenyl-Diarylpyrimidines to CNNH(2)-Biphenyl-Diarylpyrimidines. Chen, X.M., C. Pannecouque, E. De Clercq, Y.X. Lian, A. Corona, L. Dettori, E. Tramontano, S. Wang, and F.E. Chen. European Journal of Medicinal Chemistry, 2025. 285: p. 117271. PMID[39813776].
[PubMed]. HIV_03_2025.

3. Interaction Study between HIV Protease Inhibitors and Alectinib in Rats Based on an Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry Method. Chen, Y., Z. Zhou, Y. Zeng, Z. Ye, R. Li, C. Chen, J. Yang, J. Fu, T. Zhou, D. Jiang, S. Qin, X. Zhang, and C. Wang. Journal of Chromatography B: Analytical Technologies in the Biomedical Life Sciences, 2025. 1253: p. 124483. PMID[39893910].
[PubMed]. HIV_03_2025.

4. Interplay between the Cyclophilin Homology Domain of RANBP2 and MX2 Regulates HIV-1 Capsid Dependencies on Nucleoporins. Flick, H., A. Venbakkam, P.K. Singh, B. Layish, S.W. Huang, R. Radhakrishnan, M. Kvaratskhelia, A.N. Engelman, and M. Kane. mBio, 2025. 16(3): p. e0264624. PMID[39853118]. PMCID[PMC11898759].
[PubMed]. HIV_03_2025.

5. Keratin-72 Restricts HIV-1 Infection in Resting CD4(+) T Cells by Sequestering Capsids in Intermediate Filaments. He, Y., M. Xu, J. Ouyang, L. Zhao, T. Ma, X. Zhang, R. Wang, H. Shang, and G. Liang. Nature Communications, 2025. 16(1): p. 2998. PMID[40148322]. PMCID[PMC11950370].
[PubMed]. HIV_03_2025.

6. Unintegrated HIV-1 DNA Recruits cGAS Via Its Histone-Binding Domain to Escape Innate Immunity. Jahan, C., L. Bonnet-Madin, S. Machida, B. Sobhian, S. Thenin-Houssier, and M. Benkirane. The Proceedings of the National Academy of Sciences of the United States of America, 2025. 122(11): p. e2424465122. PMID[40067888]. PMCID[PMC11929445].
[PubMed]. HIV_03_2025.

7. Screening the Receptors for Mycoplasma Penetrans P35 Lipoprotein and Characterization of Its Functional Binding Domains. Li, X., X. Wang, Y. Ye, Z. Zeng, L. Chen, K. Peng, H. Xiao, S. Gao, H. Luo, and Y. Zeng. Frontiers in Cellular and Infection Microbiology, 2025. 15: p. 1525789. PMID[40166371]. PMCID[PMC11955645].
[PubMed]. HIV_03_2025.

8. Activation of CXCR3(+) Tfh Cells and B Cells in Lymph Nodes During Acute HIV-1 Infection Correlates with HIV-Specific Antibody Development. Mitchell, J.L., S. Buranapraditkun, P. Gantner, H. Takata, K. Dietze, F. N'Guessan K, J. Pollara, J. Nohara, R. Muir, E. Kroon, S. Pinyakorn, N. Tulmethakaan, S. Manasnayakorn, S. Chottanapund, P. Thantiworasit, P. Prueksakaew, N. Ratnaratorn, S. Puttamaswin, B. Nuntapinit, L. Fox, E.K. Haddad, D. Paquin-Proulx, P. Phanuphak, C.P. Sacdalan, N. Phanuphak, J. Ananworanich, D. Hsu, S. Vasan, G. Ferrari, N. Chomont, and L. Trautmann. Journal of Virology, 2025. 99(3): p. e0153224. PMID[39932316]. PMCID[PMC11915809].
[PubMed]. HIV_03_2025.

9. Targeting Ikaros and Aiolos with Pomalidomide Fails to Reactivate or Induce Apoptosis of the Latent HIV Reservoir. Pascoe, R.D., Y. Kim, A. Rhodes, J. Ong, C. Tumpach, C. Gubser, J.J. Chang, J.H. McMahon, S.R. Lewin, and T.A. Rasmussen. Journal of Virology, 2025. 99(3): p. e0167624. PMID[39902962]. PMCID[PMC11915836].
[PubMed]. HIV_03_2025.

10. Bistability and Bifurcations in HIV-1 Infection Model with Non-Monotone Responses. Pradeesh, M. and P. Mani. Scientific Reports, 2025. 15(1): p. 7265. PMID[40025097]. PMCID[PMC11873265].
[PubMed]. HIV_03_2025.

11. Intracellular HIV-1 Tat Regulator Induces Epigenetic Changes in the DNA Methylation Landscape. Rodríguez-Agustín, A., R. Ayala-Suárez, F. Díez-Fuertes, M.J. Maleno, I. de Villasante, A. Merkel, M. Coiras, V. Casanova, J. Alcamí, and N. Climent. Frontiers in Immunology, 2025. 16: p. 1532692. PMID[40103825]. PMCID[PMC11913862].
[PubMed]. HIV_03_2025.

12. Tracking HIV Persistence across T Cell Lineages During Early Art-Treated HIV-1-Infection Using a Reservoir-Marking Humanized Mouse Model. Satija, N., F. Patel, G. Schmidt, D.V. Doanman, M. Kapoor, A. La Porte, Y.C. Wang, K.M. Law, A.M. Esposito, K. Allette, K.G. Beaumont, R.P. Sebra, and B.K. Chen. Nature Communications, 2025. 16(1): p. 2233. PMID[40044684]. PMCID[PMC11883074].
[PubMed]. HIV_03_2025.

13. Targeting Latent HIV Reservoirs: Effectiveness of Combination Therapy with HDAC and PARP Inhibitors. Tibebe, H., D. Marquez, A. McGraw, S. Gagliardi, C. Sullivan, G. Hillmer, K. Narayan, C. Izumi, A. Keating, and T. Izumi. Viruses, 2025. 17(3). PMID[40143326]. PMCID[PMC11945899].
[PubMed]. HIV_03_2025.

14. Chromosome 1 Variants Associated with Decreased HIV Set-Point Viral Load Correlate with Prkab2 Expression Changes. Tough, R.H. and P.J. McLaren. Frontiers in Genetics, 2025. 16: p. 1551171. PMID[40115816]. PMCID[PMC11922826].
[PubMed]. HIV_03_2025.

15. Synergistic Activity of Second Mitochondrial-Derived Activator of Caspases Mimetic with Toll-Like Receptor 8 Agonist Reverses HIV-1-Latency and Enhances Antiviral Immunity. Vlaming, K.E., J. Jansen, G.J. de Bree, N.A. Kootstra, and T.B.H. Geijtenbeek. International Journal of Molecular Sciences, 2025. 26(6). PMID[40141220]. PMCID[PMC11941979].
[PubMed]. HIV_03_2025.

16. Inhibition of TIGIT on NK Cells Improves Their Cytotoxicity and HIV Reservoir Eradication Potential. Wang, Y., Y. Li, J. Chen, C. Guo, X. Yu, Z. Zhang, Y. Fu, X. Han, Q. Hu, H. Ding, H. Shang, and Y. Jiang. mBio, 2025. 16(3): p. e0322624. PMID[39918313]. PMCID[PMC11898710].
[PubMed]. HIV_03_2025.

17. Major Role of Dolutegravir in the Emergence of the S147G Integrase Resistance Mutation. Wirden, M., B. Abdi, S. Lambert-Niclot, M.L. Chaix, A. De Monte, B. Montes, C. Pallier, P. Bellecave, M. Bouvier-Alias, S. Raymond, S. Yerly, C. Charpentier, V. Calvez, D. Descamps, and A.G. Marcelin. Journal of Antimicrobial Chemotherapy, 2025. 80(3): p. 692-696. PMID[39786501].
[PubMed]. HIV_03_2025.

18. FBXO45 Restricts HIV-1 Replication by Inducing SQSTM1/p62-Mediated Autophagic Degradation of Tat. Xu, M., H. Hu, W. Yang, J. Zhang, H. Wang, W. Zhang, and C. Huan. Journal of Virology, 2025. 99(3): p. e0191224. PMID[39936917]. PMCID[PMC11916737].
[PubMed]. HIV_03_2025.

19. The Role of Weak Interactions in Evaluation of Inhibitory Potential of Indinavir as an HIV Protease Inhibitor and Its Comparison with Innovative Drug Candidates. Yoosefian, M. and H. Sabaghian. Computers in Biology and Medicine, 2025. 187: p. 109675. PMID[39879882].
[PubMed]. HIV_03_2025.

20. HIV-1 and BLV Are Insensitive to SERINC5 Restriction under the Cell-Cell Infection. Yu, C., F. Jiang, Y. Li, Q. Li, K. Tokunaga, D. Yang, C. Xu, N. Li, S. Li, I. Khan, Y. Xian, C. Xia, and H. Zhang. Microbiology Spectrum, 2025. 13(3): p. e0274824. PMID[39868869]. PMCID[PMC11878069].
[PubMed]. HIV_03_2025.

21. Identification of a Novel Small-Molecule Inhibitor of the HIV-1 Reverse Transcriptase Activity with a Non-Nucleoside Mode of Action. Yu, K.L., Y. Shin, D.E. Kim, J.A. Kim, J.E. Kang, P. Singh, K.W. Lee, C.M. Park, H. Kwon, S. Kim, S. Bae, and C.H. Yoon. Virology Journal, 2025. 22(1): p. 65. PMID[40055750]. PMCID[PMC11887385].
[PubMed]. HIV_03_2025.

Patent Citations

This month, no relevant HIV patents were identified.